Detalles de la búsqueda
1.
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.
Br J Clin Pharmacol
; 90(4): 976-986, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072829
2.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 22(4): 463-475, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33684370
3.
Significance of lymph node involvement in local recurrence of colorectal cancer.
J Surg Oncol
; 120(4): 722-728, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31332806
4.
Sexual quality of life evaluation after treatment among women with breast cancer under 35 years old.
Support Care Cancer
; 27(3): 879-885, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30116944
5.
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases.
Ultraschall Med
; 39(5): 544-558, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29232725
6.
Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatin.
Anticancer Drugs
; 28(2): 213-221, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27669422
7.
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
Cancer
; 122(20): 3119-3126, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27412268
8.
Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.
Int J Clin Oncol
; 20(6): 1086-92, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25931315
9.
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Lancet Healthy Longev
; 5(6): e392-e405, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759667
10.
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.
Clin Pharmacokinet
; 62(9): 1263-1274, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442917
11.
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Eur J Cancer
; 191: 112981, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506588
12.
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Sci Rep
; 13(1): 22524, 2023 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110561
13.
Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer.
Sci Rep
; 11(1): 13361, 2021 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34172805
14.
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Clin Cancer Res
; 15(10): 3633-9, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19401344
15.
Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives.
Dose Response
; 18(3): 1559325820951367, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32973417
16.
Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.
Surg Oncol
; 32: 23-29, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707314
17.
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Radiat Oncol
; 14(1): 83, 2019 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118057
18.
Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway.
Clin Cancer Res
; 13(21): 6359-68, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17975148
19.
Uncommon breast tumor attenuation artifact on radionuclide ventriculography.
Clin Nucl Med
; 33(4): 288-9, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18356673
20.
Chemotherapy of metastatic hepatoid adenocarcinoma: Literature review and two case reports with cisplatin etoposide.
Oncol Lett
; 15(1): 48-54, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29387209